September 22, 2023 Comments Off on New patent for Eyenovia drug MYDCOMBI Posted in: Patent Added Annual Drug Patent Expirations for MYDCOMBI Mydcombi is a drug marketed by Eyenovia and is included in one NDA. It is available from one supplier. The generic ingredient in MYDCOMBI…
The post New patent for Eyenovia drug MYDCOMBI appeared first on Drug…
September 22, 2023 Comments Off on New patent expiration for Glaxosmithkline Llc drug LAMICTAL XR Posted in: Uncategorized
Annual Drug Patent Expirations for LAMICTAL+XR Lamictal Xr is a drug marketed by Glaxosmithkline Llc and is included in one NDA. It is available from one supplier. There are two…
The post New patent expiration for Glaxosmithkline Llc drug LAMICTAL XR a…
